Germany: Foreign investments in German life science companies become subject to mandatory notification

Published on May 21, 2020

In response to the COVID-19 pandemic, Germany has widened the scope of its investment control to include numerous life science companies. The amendments to the Foreign Trade and Payments Ordinance ("AWV") were published on 20th May 2020 and will enter into force in the coming days.